justbacked

Biotechnology, Health Care, Medical, Therapeutics

Triveni Bio

Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.

Why join Triveni Bio?

The bet: Triveni Bio's bispecific antibody can treat the root cause of atopic dermatitis and reach patients that current approaches leave behind. If it pays off, this Watertown biotech could redraw treatment for a common skin disease and reach other immune conditions. Its first patient is dosed in a global Phase 2 study of TRIV-573, backed by $272M across three rounds and a $65M Series C lighter than most at its stage.

JustBacked's take, based on Triveni Bio's own site and its funding and hiring data.

Series C · $65M · 153d agotriveni.bio

Hiring velocity

Open roles
8
Added, 30 days
+4
Added, 7 days
+2
Closed, 30 days
1
Raised
153 days ago
Led by
Janus Henderson Investors, Goldman Sachs, Polaris Partners, OrbiMed, Cormorant Asset Management
Team size
11-50
HQ
Watertown, Massachusetts, United States
Newest role
3d ago
Tracked since
Aug 21, 2026

Where they're hiring

Clinical5
Science2

Open roles at Triveni Bio

Source: triveni.bio, checked daily.